
Arthroplasty
AAOS2018: No difference in analgesic efficacy of single-shot versus continuous ACB in TKA
177 patients scheduled for total knee arthroplasty were randomized to one of three groups for postoperative analgesia with an adductor canal block: continuous ACB, single-shot ACB or single-shot ACB plus intravenous dexamethasone. Patients were assessed primarily for cumulative opioid consumption, as well as pain scores, at 12, 24 and 48 hours after surgery. Results demonstrated significantly greater cumulative opioid consumption after 12 and 24 hours in the continuous ACB group compared to the single-shot ACB group. Cumulative opioid consumption was significantly greater in the continuous ACB group compared to the single-shot ACB plus IV dexamethasone group after 12 hours. Differences between groups after 48 hours were not statistically significant.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.